AVIR Revenue FlowAVIR Graph summaryAtea Pharmaceuticals, Inc. (AVIR). Quarter ended 2021-09-30. Reported revenue sources, expenses and earnings; undisclosed amounts are not inferred.How Atea Pharmaceuticals, Inc. made money in the latest quarterLatest-quarter revenue sources flow through cost of revenue, gross profit, operating expenses, tax, and net income. $0.03B $0.05B$-0.02B$0.04B$0.01B$-0.02B$0.01B$-0.03B Revenue from contracts with customers, excluding assessed tax$0.03BDeclared revenue$0.03B Operating expenses$0.05BOperating income$-0.02BResearch and development$0.04BGeneral and administrative$0.01BPre-tax income$-0.02BIncome tax$0.01BNet income$-0.03BComplete revenue composition table
AVIR Revenue FlowAVIR Graph summaryAtea Pharmaceuticals, Inc. (AVIR). Quarter ended 2021-09-30. Reported revenue sources, expenses and earnings; undisclosed amounts are not inferred.How Atea Pharmaceuticals, Inc. made money in the latest quarterLatest-quarter revenue sources flow through cost of revenue, gross profit, operating expenses, tax, and net income. $0.03B $0.05B$-0.02B$0.04B$0.01B$-0.02B$0.01B$-0.03B Revenue from contracts with customers, excluding assessed tax$0.03BDeclared revenue$0.03B Operating expenses$0.05BOperating income$-0.02BResearch and development$0.04BGeneral and administrative$0.01BPre-tax income$-0.02BIncome tax$0.01BNet income$-0.03BComplete revenue composition table